Direct and Indirect Thermogenic Effects of Anorectic Drugs

  • David A. Levitsky
  • Barbara J. Strupp
Part of the Advances in Nutritional Research book series (ANUR, volume 7)

Abstract

In 1937, several clinicians reported that patients receiving amphetamine for the treatment of narcolepsy and other disorders showed persistent losses in body weight (Nathanson, 1937; Davidoff and Reifenstein Jr., 1937; Ulrich, 1937). The significance of this observation was quickly realized by Lesses and Myerson (1938), who advocated the use of amphetamine for the treatment of obesity. Since that time, hundreds of articles have been written extolling the clinical effectiveness of anorectic drugs for weight reduction.

Keywords

Obesity Caffeine Norepinephrine Propranolol Cataract 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdallah, A. H., 1968, Anorectic activity of ephedrine isomers, Life Sci. 7: 665.CrossRefGoogle Scholar
  2. Acheson, K. J., Zahorska-Markiewicz, B., Pittet, P., Anantharaman, K., and Jequier, E., 1980, Caffeine and coffee: Their influence on metabolic rate and substrate utilization in normal weight and obese individuals, Am. J. Clin. Nutr. 33(5): 989.Google Scholar
  3. Arch, J. R., 1981, The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice, Am. J. Clin. Nutr. 34: 2763.Google Scholar
  4. Arch, J. R., 1983, Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats, Am. J. Clin. Nutr. 38: 549.Google Scholar
  5. Arch, J. R., Ainsworth, A. T., and Cawthorne, M. A., 1982, Thermogenic and anorectic effects of ephedrine and congeners in mice and rats, Life Sci. 30(21): 1817.CrossRefGoogle Scholar
  6. Axelrod, J., 1970, Amphetamine: Metabolism, physiological disposition and its effects on catecholamine storage, in: International Symposium on Amphetamines and Related Compounds(Pros. Mario Negri Institute for Pharmacological Research, Milan, Italy), Raven Press, New York.Google Scholar
  7. Boothby, W. M., and Rowntree, L. G., 1924, Drugs and basal metabolism, J. Pharmacol. Exp. Therap. 22: 99.Google Scholar
  8. Bukowiecki, L., Jahjah, L., and Follea, N., 1982, Ephedrine; a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors, Int. J. Obesity 6(4): 343.Google Scholar
  9. Burn, J. H., Leach, E. H., Rand, M. J., and Thompson, J. W., 1959, Peripheral effects of nicotine and acetylcholine resembling those of sympathetic stimulators, J. Physiol. (London) 148: 332.Google Scholar
  10. Chapai, J., and Loubatieres-Mariani, M. M., 1978, Effect of nicotine on insulin secretion in the isolated perfused rat pancreas, C. R. Seances Soc. Biol. Fel. 172: 156.Google Scholar
  11. Comai, K., Trescari, A. C., and Sullivan, A. C., 1978, Comparative effects of amphetamine and fenfluramine on lipid biosynthesis and absorption in the rat, Biochem. Pharmacol. 27: 1987.CrossRefGoogle Scholar
  12. Davidoff, E., and Reifenstein Jr., E. C., 1937, The stimulating action of benzedrine sulfate: A comparative study of the responses of normal persons and depressed patients, JAMA 108: 1770.CrossRefGoogle Scholar
  13. Durnin, J. V. G. A., and Womersley, J., 1973, The metabolic effects and the composition of the tissue test, in weight reduction by obese patients on treatment with fenfluramine, Br. J. Pharmacol. 49: 115.CrossRefGoogle Scholar
  14. Evans, E., and Miller, D. S., 1977, The effect of ephedrine on the oxygen consumption of fed and fasted subjects, Proc. Nutr. Soc. 36(3): 136A.Google Scholar
  15. Garrow, J. S., Belton, E. A., and Daniels, A., 1972, A controlled investigation of the glycol-lyptic action of fenfluramine, Lancet ii:559.Google Scholar
  16. Grollman, A., 1930, The action of alcohol, caffeine and tobacco on the cardiac output (and its related function) of normal man, J. Pharmacol. Exp. Therap. 39: 313.Google Scholar
  17. Haldi, J., Bachmann, G., Ensor, C., and Wynn, W., 1941, The effects of various amounts of caffeine on the gaseous exchange and the respiratory quotient in man, J. Nutr. 21: 307.Google Scholar
  18. Harris, S. C., Ivy, A. C., and Searle, L. M., 1947, The mechanism of amphetamine-induced loss of weight, JAMA 174: 1468.CrossRefGoogle Scholar
  19. Higgins, H. L., and Means, J. H., 1915, The effect of certain drugs on the respiration and gaseous metabolism in normal human subjects, J. Pharmacol. Exp. Therap. 7: 1.Google Scholar
  20. Himms-Hagen, J., 1976, Cellular thermogenesis, Ann. Rev. Physiol. 38: 315.CrossRefGoogle Scholar
  21. Hopkin, L. J., and Davis, J. C., 1976, Peripheral effects of anorectic drugs, Lancet i:754.Google Scholar
  22. Hohenegger, M., Kramar, R., Om, P., Weissel, M., and Watschinger, R., 1982, Influence of triiodothyronine, amphetamine, and dinitrophenol (DNP) on the induced metabolic rate in uremic and acidotic rats, Exp. Pathol. 22(1): 37.CrossRefGoogle Scholar
  23. Horner, W. D., 1942, Dinitrophenol and its relation. to formation of cataract, Arch. Ophth. (Chicago) 27: 1097.CrossRefGoogle Scholar
  24. Horst, K., Willson, R. J., and Smith, R. G., 1936, The effect of coffee and decaffeinated coffee on oxygen consumption, pulse rate, and blood pressure, J. Pharmacol. Exp. Therap. 58: 294.Google Scholar
  25. Lang, S. S., Danforth Jr., E., and Lien, E. L., 1983, Anorectic drugs which stimulate thermogenesis, Life Sci. 33: 1269.CrossRefGoogle Scholar
  26. Le Douarec, J. C., and Schmitt, H., 1964, Comparison pharmacologique de sept. medicaments anorexigenes, Therapie 14: 831.Google Scholar
  27. Lesses, M. F., and Myerson, A., 1938, Human autonomic pharmacology: Benzedrine sulfate as an aid in treatment of obesity, New Engl. J. Med. 218: 119.CrossRefGoogle Scholar
  28. Lesses, M. F., and Myerson, A., 1938, Human autonomic pharmacology: Benzedrine sulfate as an aid in treatment of obesity, New Engl. J. Med. 218: 119.CrossRefGoogle Scholar
  29. Levitsky, D. A., Strupp, B. J., and Lupoli, J., 1981, Tolerance to anorectic drugs: Pharmacological or artifactual? Pharmacol. Biochem. Behav. 14: 661.CrossRefGoogle Scholar
  30. Levitsky, D. A., Green, P. S., and Obarzanek, E., 1983, Calorigenic effect of nicotine depends upon the ingestion of food. Paper presented at International Congress of Obesity, Story, Vermont.Google Scholar
  31. Malchow-Moller, A., Larsen, S., Hey, H., Stockholm, K. H., Juhl, E., and Quaade, R., 1981, Ephedrine as an anorectic: The story of the “Elsmore Pill”, Int. J. Obesity 5: 183.Google Scholar
  32. Massoudi, M., and Miller, D. S., 1977, Ephedrine, a thermogenic and potential slimming drug, Proc. Nutr. Soc. 36: 135A.Google Scholar
  33. Massoudi, M., Evans, E., and Miller, D. S., 1983, Thermogenic drugs for the treatment of obesity: Screening using obese rats and mice, Ann. Nutr. Metab. 27(1): 26.CrossRefGoogle Scholar
  34. Miller, D. S., Stock, M. J., and Stuart, J. A., 1974, The effects of caffeine and carnitine on the oxygen consumption of fed and fasted subjects, Proc. Nutr. Soc. 33: 28A.Google Scholar
  35. Nathanson, M. H., 1937, Central action of beta-aminopropylbenzene (benzedrine), JAMA 108: 528.CrossRefGoogle Scholar
  36. Newsholme, E. A., and Crabtree, B., 1976, Substrate cycles in metabolic regulation and heat generation, Biochem. Soc. Symp. 41: 61.Google Scholar
  37. Offermeier, J., and du Preez, H. G., 1978, Effects of anorectics on uptake and release of monoamine in synaptosomes, in: Central Mechanisms of Anorectic Drugs( S. Garattini and R. Samanin, eds.), Raven Press, New York.Google Scholar
  38. Pawan, G. L. S., 1969, Effect of fenfluramine on blood lipids in man, Lancet i:498.Google Scholar
  39. Pawan, G. L. S., 1970, Metabolic studies on the effect of fenfluramine in man and the mouse, in: Amphetamines and Related Compounds(E. Costa and S. Garattini, eds.), pp. 641–651, Raven Press, New York.Google Scholar
  40. Petrie, J. C., Morvat, J. A., Bewsher, P. D., and Stowers, J. O., 1975, Metabolic effect of fenfluramine: A double-blind study, Postgrad. Med. J. 51(Suppl. 1): 139.Google Scholar
  41. Quaade, F., Pakkenberg, H., and Juhl, E., 1974, Levo-dopa as a treatment for obesity, Acta Med. Scand. 195: 129.CrossRefGoogle Scholar
  42. Robbins, B. H., 1944, Dinitrophenol cataract: Production in an experimental animal, J. Pharmacol. Exp. Therap. 80: 264.Google Scholar
  43. Rothwell, N. J., and Stock, M. J., 1979, A role for adipose tissue in diet-induced thermogenesis, Nature(London) 281: 31.CrossRefGoogle Scholar
  44. Rothwell, N. J., Stock, M. J., and Wyllie, M. G., 1981, Sympathetic mechanisms in diet-induced thermogenesis: Modification by ciclazindol and anorectic drugs, Br. J. Pharmacol. 74(3): 539.CrossRefGoogle Scholar
  45. Strubelt, O., and Siegers, C. P., 1969, Zukm mechanismus der kalonginen wirkung non theophyllin and caffein, Biochem. Pharmacol. 18: 1207.CrossRefGoogle Scholar
  46. Tjalve, H., and Popov, D., 1973, Effect of nicotine and nicotine metabolites on insulin secretion from rabbit pancreas pieces, Endocrinology 92: 1343.CrossRefGoogle Scholar
  47. Turner, P., 1978, How do anti-obesity drugs works, Int. J. Obesity 2: 343.Google Scholar
  48. Turtle, J. P., and Burgess, J., 1973, Hypoglycemic action of fenfluramine in diabetes mellitus, Diabetes 27: 858.Google Scholar
  49. Ulrich, H., 1937, Narcolepsy and its treatment with benzedrine sulfate, New Engl. J. Med. 217: 696.CrossRefGoogle Scholar
  50. Wales, J. K., 1980, The effect of fenfluramine on weight loss during restricted dietary regimens, Int. J. Obesity 4: 127.Google Scholar
  51. Wang, L. C., and Anholt, E. C., 1982, Elicitation of supramaximal thermogenesis by aminophylline in the rat, J. Appl. Physiol. 53(1): 16.Google Scholar
  52. Wellman, P. J., 1983, Influence of amphetamine on brown adipose thermogenesis, Res. Comm. Chem. Pathol. Pharm. 41(1): 173.Google Scholar
  53. Wilson, J. P. D., and Galton, J. D., 1971, The effects of drugs on lipogenesis from glucose and palmate in human adipose tissue, Horm. Metab. Res. 3: 262.CrossRefGoogle Scholar
  54. Yelnosky, J. O., and Lawlor, R. B., 1970, A comparative study of the pharmacological action of amphetamine and fenfluramine, Arch. Int. Pharmacodyn. Therap. 184: 374.Google Scholar
  55. Yen, T. T., McKee, M. M., and Bemis, K. G., 1981, Ephedrine reduces weight of viable yellow obese mice (Avy/a), Life Sci. 28: 119.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • David A. Levitsky
    • 1
  • Barbara J. Strupp
    • 1
  1. 1.Division of Nutritional SciencesCornell UniversityIthacaUSA

Personalised recommendations